Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Rusfertide for PV: Stopping Phlebotomies & Improving Symptoms #PV
HealthTreeDescription
Dr. Alessandro Lucchesi discusses rusfertide, a new treatment for polycythemia vera (PV) that eliminates the need for frequent blood draws (phlebotomies).
WHAT IS PV?
PV is a blood disorder where the bone marrow produces too many red blood cells, causing blood clots and requiring regular phlebotomies to manage.
THE SOLUTION - RUSFERTIDE:
Rusfertide is a hepcidin mimetic that works by depleting iron from the bloodstream, starving the bone marrow so it can't overproduce red blood cells. This stops the need for phlebotomies.
KEY ADVANTAGES:
- Weekly subcutaneous injection (easy to self-administer)
- Safe and well-tolerated
- Phase 3 trial shows promising results
OTHER DEVELOPMENTS:
- Similar hepcidin drugs in phase 3 trials
- Ginostat: an epigenetic modulator that may stop disease progression
- Future biomarkers to match patients with best treatment
Learn more: https://linktr.ee/HealthTreeUniversity
TIMESTAMPS:
0:00 Introduction
0:18 What is Polycythemia Vera?
0:42 Rusfertide: How It Works
0:58 Weekly Injection & Administration
1:05 Phase 3 Trial Results
1:26 Similar Hepcidin Drugs
1:57 Epigenetic Modulators & Future Treatments
#PV #PolycythemiaVera #Rusfertide #EHA2026 #NewTreatment